Trandolapril Hydrochloride is an oral angiotensin-converting enzyme (ACE) inhibitor widely utilized in the treatment of hypertension and heart failure. By blocking the conversion of angiotensin I to angiotensin… Read more
Trandolapril Hydrochloride is an oral angiotensin-converting enzyme (ACE) inhibitor widely utilized in the treatment of hypertension and heart failure. By blocking the conversion of angiotensin I to angiotensin II, this medication effectively reduces systemic blood pressure and cardiac workload. To ensure the safety and efficacy of pharmaceutical formulations, laboratories rely on high-quality reference standards for Trandolapril Hydrochloride, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are critical for accurate impurity profiling, method validation, and rigorous quality control throughout the drug development and manufacturing lifecycle. Utilizing these specialized analytical tools allows researchers and quality assurance professionals to detect, identify, and quantify related substances, ensuring compliance with strict regulatory standards for therapeutic products.